The Bio Report cover image

The Year in Biotech and What’s Ahead in 2023

The Bio Report

00:00

Is Amulex's ALS Drug Approved?

This year, we saw the approval of amulex's ALS drug. How significant was this? I think it was pretty significant. The question is, you know, our insurance company will pay for it. And so that is going to be another story to look at and to pay attention to in 2023.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app